Clinical Trials Browser

Phase 2 × Kidney Diseases × Sorafenib × Clear all

NCT00854620 2015-06-19

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

Phase 2 Completed

9 enrolled 3 charts

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms